Objective: In this study, the objective was to evaluate the cardiovascular and metabolic effects in men with male pattern alopecia beginning before 30 years of age.
Methods: Total of 81 people (41 androgenetic alopecia (AGA) and 40 healthy individuals) were included in the study. Twenty-four-hour ambulatory blood pressure (ABP) measurement, high sensitive C-reactive protein (hsCRP), galectin-3 were studied. Hamilton-Norwood scale (HNS) was used to determine the AGA types of the cases.
Results: The mean age in the AGA and control groups was 30.3 ± 7.5 and 30.8 ± 6.0, respectively. Twenty-four-hour ABP measurements, hsCRP, and galectin-3 were similar in both groups. There was a positive correlation between HNS grade with age, BMI, triglyceride levels and fasting blood glucose levels in individuals with AGA. Similarly, there was a positive correlation between HNS grade with daytime pulse wave velocity and night-time reflection magnitude. A significant positive correlation was determined between hsCRP with BMI and waist circumference, and between galectin-3 with BMI, waist circumference, hip circumference, HOMA-IR in individuals with AGA.
Conclusions: This study shows that AGA patients are similar to the normal population in terms of insulin resistance or metabolic syndrome components. However, hsCRP and galectin-3 appear to be associated with cardiovascular disease risk factors in individuals with AGA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/1354750X.2021.2013539 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of serum galectin-3 concentration as a potential biomarker in exudative-type age-related macular degeneration.
Sci Rep
December 2024
Department of Ophthalmology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, 53100, Turkey.
To investigate the effect of serum galectin-3 on naive neovascular AMD and its use as a serum marker by revealing the variation in this molecule between patient and control groups. Fifty-six naive neovascular AMD patients and 30 healthy control age-matched healthy subjects were included in this prospective case‒control study. Blood samples were obtained and used for analysis of complete blood count; High sensitivity C-reactive protein (HsCRP), erythrocyte sedimentation rate (ESR), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG), total cholesterol, homocysteine, HbA1c and galectin-3 levels.
View Article and Find Full Text PDFAssessment of novel cardiovascular biomarkers in chronic obstructive pulmonary disease.
BMC Pulm Med
November 2024
Respiratory Care Clinic Tokyo, Institute of Clinical Respirology, 1-12-5-1F, Kyobashi, Chuo-ku, Tokyo, 104-0031, Japan.
Background: Cardiovascular disease is a common comorbidity in chronic obstructive pulmonary disease (COPD) and pre-COPD patients, contributing significantly to morbidity and mortality. We aimed to investigate whether Galectin-3 (Gal-3) levels correlate with cardiovascular biomarkers and cardiopulmonary function in COPD and pre-COPD patients to assess its potential role as a marker for cardiovascular comorbidity.
Methods: Community-dwelling adults with and without COPD were recruited.
Heart failure biomarkers and prediction of early left ventricle remodeling after acute coronary syndromes.
Clin Biochem
October 2024
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Cardiology Department. Hospital, Clínico Universitario, Valencia, Spain; Fundación de Investigación INCLIVA, Valencia, Spain; Departamento de medicina, Universidad de Valencia, Valencia, Spain.
Introduction: Several biomarkers are characteristically elevated in patients with acute heart failure (AHF). Our hypothesis was they could predict early changes in left ventricular (LV) characteristics in acute coronary syndrome (ACS) patients. The objective of this study was two-fold: a) compare circulating concentrations of NT-pro BNP, CA-125, ST2, galectin-3 and pro-adrenomedullin among 4 groups of individuals (healthy controls; patients with ACS without AHF; patients with ACS and AHF and patients admitted for AHF); and b) evaluate whether these biomarkers predict adverse LV remodeling and ejection fraction changes in ACS.
View Article and Find Full Text PDFBlood Biomarkers Predict 10-Year Clinical Outcomes in Adult Patients With Congenital Heart Disease.
JACC Adv
September 2024
Department of Cardiology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Background: The adult congenital heart disease (ACHD) population is growing and risk prediction is important to predict adverse outcome and consult patients during their lifecourse.
Objectives: This study aims to describe the long-term prognostic value of blood biomarkers in ACHD.
Methods: In this prospective observational cohort study, 602 patients with moderate or complex ACHD were included (median age 32.
Elevated cerebrospinal fluid galectin-3 and associated cytokines after severe traumatic brain injury in patients.
Medicine (Baltimore)
August 2024
Department of Neurosurgery, Chang Gung Memorial Hospital at Linkou, Chang Gung Medical College and University, Taoyuan City, Taiwan.
Article Synopsis
- * Researchers divided the sTBI patients into three groups based on disability severity using the Modified Rankin Score, analyzing the relationship between biomarker levels and patient outcomes over the week following the injury.
- * Findings showed that elevated levels of specific cytokines, particularly IL-6, were associated with different outcomes among the patient groups, indicating their potential use in predicting recovery or decline in sTBI cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!